These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32432774)

  • 41. MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma.
    Zang CS; Huang HT; Qiu J; Sun J; Ge RF; Jiang LW
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4890-4900. PubMed ID: 32432752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curcumin inhibits the viability, migration and invasion of papillary thyroid cancer cells by regulating the miR-301a-3p/STAT3 axis.
    Liang Y; Kong D; Zhang Y; Li S; Li Y; Dong L; Zhang N; Ma J
    Exp Ther Med; 2021 Aug; 22(2):875. PubMed ID: 34194553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.
    Chen J; Yin J; Liu J; Zhu RX; Zheng Y; Wang XL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1145-1150. PubMed ID: 30779083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sevoflurane Suppresses the Migration, Invasion, and Epithelial-Mesenchymal Transition of Breast Cancer Cells Through the miR-139-5p/ARF6 Axis.
    Wu T; Sun L; Wang C; Yu P; Cheng L; Chen Y
    J Surg Res; 2021 Feb; 258():314-323. PubMed ID: 33317757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propofol inhibits proliferation and metastasis by up-regulation of miR-495 in JEG-3 choriocarcinoma cells.
    Sun H; Wang Y; Zhang W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1738-1745. PubMed ID: 31046467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
    Wang R; Zhao L; Ji L; Bai L; Wen Q
    Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of
    Chen D; Huang Z; Ning Y; Lou C
    Cancer Manag Res; 2020; 12():8757-8771. PubMed ID: 33061573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
    Zhou SL; Tang QL; Zhou SX; Ren RZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
    Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
    Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
    [No Abstract]   [Full Text] [Related]  

  • 52. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
    Ji L; Fan X; Zhou F; Gu J; Deng X
    J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.
    Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition.
    Guan Y; Bhandari A; Xia E; Kong L; Zhang X; Wang O
    Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):116-124. PubMed ID: 31942970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways.
    Jiang HC; Chen XR; Sun HF; Nie YW
    Hum Cell; 2020 Jan; 33(1):175-184. PubMed ID: 31782107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145.
    Lei H; Gao Y; Xu X
    Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):588-597. PubMed ID: 28645161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lentivirus-mediated shRNA interference of trefoil factor 3 blocks cell viability, migration and invasion in the papillary thyroid carcinoma cells.
    Wu J; Zhang H; Zhang W; Zhang J; Lin X; Xue G; Gao F
    Neoplasma; 2018; 65(2):169-177. PubMed ID: 29534576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
    Zhang Z; Li SY; Zhang LB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOX2-induced upregulation of lncRNA LINC01510 promotes papillary thyroid carcinoma progression by modulating miR-335/SHH and activating Hedgehog pathway.
    Li Q; Wang XJ; Jin JH
    Biochem Biophys Res Commun; 2019 Dec; 520(2):277-283. PubMed ID: 31590919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.